BJDX (STOCKS)
Bluejay Diagnostics, Inc. Common Stock
$1.810000
+0.030000 (+1.69%)
Prev close: $1.780000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Indranil Dey
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1.71M
- Employees
- 5
- P/E (TTM)
- -0.07
- P/B (TTM)
- 0.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2023 (Q4)
|
$-2,976.00 | $-1,117.92 | -1,858.0800 | -166.21% |
|
Sep 2023 (Q3)
|
$-3,328.00 | $-1,330.08 | -1,997.9200 | -150.21% |
|
Jun 2023 (Q2)
|
$-4,400.00 | $-2,448.00 | -1,952.0000 | -79.74% |
|
Mar 2023 (Q1)
|
$-3,840.00 | $-1,958.40 | -1,881.6000 | -96.08% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $104.49K |
| Operating Expenses | $6.95M |
| Research and Development | $3.05M |
| Other Operating Expenses | $3.91M |
| Operating Income/Loss | -$6.95M |
| Income/Loss From Continuing Operations After Tax | -$6.85M |
| Income/Loss From Continuing Operations Before Tax | $24.45M |
| Income Tax Expense/Benefit | $31.30M |
| Net Income/Loss | -$6.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$15.25 |
| Diluted Earnings Per Share | -$15.25 |
| Basic Average Shares | 449,043 |
| Diluted Average Shares | 449,043 |
| Assets | $7.12M |
| Current Assets | $5.46M |
| Noncurrent Assets | $1.66M |
| Fixed Assets | $1.53M |
| Other Non-current Assets | $121.19K |
| Liabilities | $1.14M |
| Current Liabilities | $1.12M |
| Accounts Payable | $214.26K |
| Other Current Liabilities | $904.94K |
| Noncurrent Liabilities | $24.75K |
| Equity | $5.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.98M |
| Liabilities And Equity | $7.12M |
| Net Cash Flow From Operating Activities | -$6.05M |
| Net Cash Flow From Operating Activities, Continuing | -$6.05M |
| Net Cash Flow From Investing Activities | -$173.74K |
| Net Cash Flow From Investing Activities, Continuing | -$173.74K |
| Net Cash Flow From Financing Activities | $7.09M |
| Net Cash Flow From Financing Activities, Continuing | $7.09M |
| Net Cash Flow | $862.93K |
| Net Cash Flow, Continuing | $862.93K |
| Comprehensive Income/Loss | -$6.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.85M |
| Other Comprehensive Income/Loss | $0.00 |